Ieq Capital LLC acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 310,352 shares of the company’s stock, valued at approximately $7,178,000. Ieq Capital LLC owned approximately 0.15% of Bath & Body Works as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares in the last quarter. Danske Bank A S bought a new position in shares of Bath & Body Works in the 3rd quarter worth $39,000. Global Retirement Partners LLC purchased a new stake in shares of Bath & Body Works during the 4th quarter worth $31,000. Activest Wealth Management purchased a new stake in shares of Bath & Body Works during the 4th quarter worth $32,000. Finally, Elevation Wealth Partners LLC boosted its position in Bath & Body Works by 5,278.8% during the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after purchasing an additional 1,742 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
BBWI has been the subject of a number of recent research reports. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Telsey Advisory Group lowered their price target on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a report on Thursday, May 28th. TD Cowen lifted their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. The Goldman Sachs Group lowered shares of Bath & Body Works from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $23.00 to $19.00 in a research note on Wednesday, July 8th. Finally, Wells Fargo & Company raised their target price on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Hold” and a consensus target price of $22.57.
Bath & Body Works Price Performance
Shares of BBWI stock opened at $19.47 on Monday. The business has a fifty day moving average of $20.47 and a 200 day moving average of $20.08. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The firm has a market capitalization of $3.92 billion, a price-to-earnings ratio of 5.47, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the previous year, the business earned $0.49 EPS. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.1%. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.
Bath & Body Works Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Read More
- Five stocks we like better than Bath & Body Works
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
